Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists
Members with known genetic predispositions to low GLP-1 pathway activity may derive particular benefit from dietary tools like allulose that activate this pathway naturally
Each medication works differently, targets different metabolic pathways, and may be more appropriate depending on your health history, weight loss goals, medical conditions, and previous treatment experience
The study found that in the initial unadjusted population, those taking tirzepatide and semaglutide differed
Effects of tirzepatide vs semaglutide on -cell function, insulin sensitivity, and glucose control during a meal test
They were allowed to acclimatize for two weeks